A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The aim of this study was to evaluate the safety and tolerability of HRS-9821 Powder for Inhalation administered in a single dose in healthy individuals and multiple doses in patients with COPD。
Epistemonikos ID: 677b2b45676f052d84dc66562773902a7b3d8cb0
First added on: May 05, 2026